최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기약학회지 = Yakhak hoeji, v.52 no.4, 2008년, pp.288 - 292
이경희 (영남대학교 임상약학대학원) , 스리니바산샨무감 (영남대학교 약학대학) , 렌가라잔바스카란 (영남대학교 약학대학) , 산토쉬쿠마르나가야스리라만 (영남대학교 약학대학) , 용철순 (영남대학교 약학대학) , 최한곤 (영남대학교 약학대학) , 우종수 (영남대학교 약학대학) , 유봉규 (영남대학교 약학대학)
Olanzapine, an atypical antipsychotic, has been widely used for the treatment of schizophrenia and bipolar disease. Although olanzapine is less associated with extrapyramidal symptoms and neuroleptic malignant syndrome compared to existing typical antipsychotics, the use of this drug has a problemat...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Lund, B. and Perry, P. : Olanzapine: an atypical antipsychotic for schizophrenia. Expert Opin. Pharmacother. 1, 305 (2000)
Bhana, N., Foster, R., Olney, R. and Plosker, G. : Olanzapine: an updated review of its use in the management of schizophrenia. Drugs 61, 111 (2001)
Matza, L., Baker, T. and Revicki, D. : Efficacy of olanzapine and ziprasidone for the treatment of schizophrenia: a systematic review. CNS Drugs 19, 499 (2005)
Yatham, L., Goldstein, J., Vieta, E., Bowden, C., Grunze, H., Post, R., Suppes, T. and Calabrese, J. : Atypical antipsychotics in bipolar depression: potential mechanisms of action. J. Clin. Psychiatry 66(Suppl 5), 40 (2005)
Eli Lilly and Company. $Zyprexa^{TM}$ (olanzapine). http:// pi.lilly.com/us/zyprexa-pi.pdf (accessed on May 9, 2008 May)
McClellan, J. : Olanzapine and pediatric bipolar disorder: evidence for efficacy and safety concerns. Am. J. Psychiatry 164, 1462 (2007)
Strawn, J. and Delbello, M. : Olanzapine for the treatment of bipolar disorder in children and adolescents. Expert Opin. Pharmacother. 9, 467, (2008)
Ketter, T., Houston, J., Adams, D., Risser, R., Meyers, A., Williamson, D. and Tohen, M. : Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes. J. Clin. Psychiatry 67, 95, (2006)
Chengappa, K., Pollock, B., Parepally, H., Levine, J., Kirshner, M., Brar, J. and Zoretich, R. : Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine. J. Clin. Psychopharmacol. 20, 311 (2000)
Mulsant, B., Gharabawi, G., Bossie, C., Mao, L., Martinez, R., Tune, L., Greenspan, A., Bastean, J. and Pollock, B. : Correlates of anticholinergic activity in patients with dementia and psychosis treated with risperidone or olanzapine. J. Clin. Psychiatry 65, 1708 (2004)
Isaac, M. and Isaac, M. : Olanzapine and weight gain. Am. J. Psychiatry 162, 1764 (2005)
http://lawprofessors.typepad.com/mass_tort_litigation/zyprexa/ index.html (accessed on May 8, 2008)
http://www.symbyax.com/prescribing/consumer_safety.jsp (accessed on May 8, 2008)
Smith, E., Rothschild, A., Heo, M., Peasley-Miklus, C., Caswell, M., Papademetriou, E., Flint, A., Mulsant, B. and Meyers, B. : Weight gain during olanzapine treatment for psychotic depression: effects of dose and age. Int. Clin. Psychopharmacol. 23, 130 (2008)
Meyer, J. : A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: metabolic outcomes after 1 year. J. Clin. Psychiatry 63, 425 (2002)
Kinon, B., Kaiser, C., Ahmed, S., Rotelli, M. and Kollack- Walker, S. : Association between early and rapid weight gain and change in weight over one year of olanzapine therapy in patients with schizophrenia and related disorders. J. Clin. Psychopharmacol. 25, 255 (2005)
Lipkovich, I., Citrome, L., Perlis, R., Deberdt, W., Houston, J., Ahl, J. and Hardy, T. : Early predictors of substantial weight gain in bipolar patients treated with olanzapine. J. Clin. Psychopharmacol. 26, 316 (2006)
Fleischhaker, C., Heiser, P., Hennighausen, K., Herpertz- Dahlmann, B., Holtkamp, K., Mehler-Wex, C., Rauh, R., Remschmidt, H., Schulz, E. and Warnke, A. : Weight gain associated with clozapine, olanzapine and risperidone in children and adolescents. J. Neural. Transm. 114, 273 (2007)
※ AI-Helper는 부적절한 답변을 할 수 있습니다.